181 related articles for article (PubMed ID: 37511480)
41. Glycoengineered nanoparticles enhance the delivery of 5-fluoroucil and paclitaxel to gastric cancer cells of high metastatic potential.
Fernandes E; Ferreira D; Peixoto A; Freitas R; Relvas-Santos M; Palmeira C; Martins G; Barros A; Santos LL; Sarmento B; Ferreira JA
Int J Pharm; 2019 Oct; 570():118646. PubMed ID: 31465836
[TBL] [Abstract][Full Text] [Related]
42. Preparation and Characterization of Paclitaxel-loaded PLGA nanoparticles coated with cationic SM5-1 single-chain antibody.
Kou G; Gao J; Wang H; Chen H; Li B; Zhang D; Wang S; Hou S; Qian W; Dai J; Zhong Y; Guo Y
J Biochem Mol Biol; 2007 Sep; 40(5):731-9. PubMed ID: 17927907
[TBL] [Abstract][Full Text] [Related]
43. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response.
Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314
[TBL] [Abstract][Full Text] [Related]
44. Effect of metformin/irinotecan-loaded poly-lactic-co-glycolic acid nanoparticles on glioblastoma: in vitro and in vivo studies.
Taghizadehghalehjoughi A; Hacimuftuoglu A; Cetin M; Ugur AB; Galateanu B; Mezhuev Y; Okkay U; Taspinar N; Taspinar M; Uyanik A; Gundogdu B; Mohammadzadeh M; Nalci KA; Stivaktakis P; Tsatsakis A; Jung TW; Jeong JH; Abd El-Aty AM
Nanomedicine (Lond); 2018 Jul; 13(13):1595-1606. PubMed ID: 30028222
[TBL] [Abstract][Full Text] [Related]
45. Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers.
Wohlfart S; Khalansky AS; Gelperina S; Maksimenko O; Bernreuther C; Glatzel M; Kreuter J
PLoS One; 2011 May; 6(5):e19121. PubMed ID: 21573151
[TBL] [Abstract][Full Text] [Related]
46.
Gibbens-Bandala B; Morales-Avila E; Ferro-Flores G; Santos-Cuevas C; Meléndez-Alafort L; Trujillo-Nolasco M; Ocampo-García B
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110043. PubMed ID: 31546458
[TBL] [Abstract][Full Text] [Related]
47. Targeted delivery of nano-PTX to the brain tumor-associated macrophages.
Zou L; Tao Y; Payne G; Do L; Thomas T; Rodriguez J; Dou H
Oncotarget; 2017 Jan; 8(4):6564-6578. PubMed ID: 28036254
[TBL] [Abstract][Full Text] [Related]
48. Doxorubicin-loaded PLGA nanoparticles for the chemotherapy of glioblastoma: Towards the pharmaceutical development.
Maksimenko O; Malinovskaya J; Shipulo E; Osipova N; Razzhivina V; Arantseva D; Yarovaya O; Mostovaya U; Khalansky A; Fedoseeva V; Alekseeva A; Vanchugova L; Gorshkova M; Kovalenko E; Balabanyan V; Melnikov P; Baklaushev V; Chekhonin V; Kreuter J; Gelperina S
Int J Pharm; 2019 Dec; 572():118733. PubMed ID: 31689481
[TBL] [Abstract][Full Text] [Related]
49. Cytotoxicity of paclitaxel incorporated in PLGA nanoparticles on hypoxic human tumor cells.
Jin C; Bai L; Wu H; Song W; Guo G; Dou K
Pharm Res; 2009 Jul; 26(7):1776-84. PubMed ID: 19384463
[TBL] [Abstract][Full Text] [Related]
50. CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
Byeon Y; Lee JW; Choi WS; Won JE; Kim GH; Kim MG; Wi TI; Lee JM; Kang TH; Jung ID; Cho YJ; Ahn HJ; Shin BC; Lee YJ; Sood AK; Han HD; Park YM
Cancer Res; 2018 Nov; 78(21):6247-6256. PubMed ID: 30115698
[TBL] [Abstract][Full Text] [Related]
51. Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles.
Gullotti E; Park J; Yeo Y
Pharm Res; 2013 Aug; 30(8):1956-67. PubMed ID: 23609560
[TBL] [Abstract][Full Text] [Related]
52. A Photopolymerized Semi-Interpenetrating Polymer Networks-Based Hydrogel Incorporated with Nanoparticle for Local Chemotherapy of Tumors.
Wang Y; Li Q; Zhou JE; Tan J; Li M; Xu N; Qu F; Chen J; Li J; Wang J; Liang Z; Yu L; Wang Y; Yan Z
Pharm Res; 2021 Apr; 38(4):669-680. PubMed ID: 33796952
[TBL] [Abstract][Full Text] [Related]
53. Effect of Paclitaxel/etoposide co-loaded polymeric nanoparticles on tumor size and survival rate in a rat model of glioblastoma.
Maleki H; Hosseini Najafabadi MR; Webster TJ; Hadjighassem MR; Sadroddiny E; Ghanbari H; Khosravani M; Adabi M
Int J Pharm; 2021 Jul; 604():120722. PubMed ID: 34022255
[TBL] [Abstract][Full Text] [Related]
54. Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells.
Le Broc-Ryckewaert D; Carpentier R; Lipka E; Daher S; Vaccher C; Betbeder D; Furman C
Int J Pharm; 2013 Oct; 454(2):712-9. PubMed ID: 23707251
[TBL] [Abstract][Full Text] [Related]
55. Development and optimization of paclitaxel loaded Eudragit/PLGA nanoparticles by simplex lattice mixture design: Exploration of improved hemocompatibility and in vivo kinetics.
Jeswani G; Chablani L; Gupta U; Sahoo RK; Nakhate KT; Ajazuddin
Biomed Pharmacother; 2021 Dec; 144():112286. PubMed ID: 34653755
[TBL] [Abstract][Full Text] [Related]
56. PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells.
Su WP; Cheng FY; Shieh DB; Yeh CS; Su WC
Int J Nanomedicine; 2012; 7():4269-83. PubMed ID: 22904633
[TBL] [Abstract][Full Text] [Related]
57. Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma.
Cai JX; Liu JH; Wu JY; Li YJ; Qiu XH; Xu WJ; Xu P; Xiang DX
Int J Nanomedicine; 2022; 17():837-854. PubMed ID: 35228800
[TBL] [Abstract][Full Text] [Related]
58. Folic acid functionalized nanoparticles for enhanced oral drug delivery.
Roger E; Kalscheuer S; Kirtane A; Guru BR; Grill AE; Whittum-Hudson J; Panyam J
Mol Pharm; 2012 Jul; 9(7):2103-10. PubMed ID: 22670575
[TBL] [Abstract][Full Text] [Related]
59. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Chen YC
Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
[TBL] [Abstract][Full Text] [Related]
60. Distribution of β-carotene-encapsulated polysorbate 80-coated poly(D, L-lactide-co-glycolide) nanoparticles in rodent tissues following intravenous administration.
Miyazawa T; Nakagawa K; Harigae T; Onuma R; Kimura F; Fujii T; Miyazawa T
Int J Nanomedicine; 2015; 10():7223-30. PubMed ID: 26664113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
